Cancer Research TCM Europe  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 2581, April 15, 2008. doi: 10.1158/0008-5472.CAN-08-0088
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swisher, E. M.
Right arrow Articles by Taniguchi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swisher, E. M.
Right arrow Articles by Taniguchi, T.

Priority Reports

Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance

Elizabeth M. Swisher1,2, Wataru Sakai3,4, Beth Y. Karlan5, Kaitlyn Wurz1,2, Nicole Urban4 and Toshiyasu Taniguchi3,4

Departments of 1 Obstetrics and Gynecology and 2 Medicine, University of Washington; Divisions of 3 Human Biology and 4 Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; and 5 Cedars-Sinai Medical Center, Women's Cancer Research Institute, Los Angeles, California

Requests for reprints: Toshiyasu Taniguchi, Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, C1-015, Seattle, WA 98109-1024. Phone: 206-667-7283; Fax: 206-667-5815; E-mail: ttaniguc{at}fhcrc.org.

Key Words: DNA damage and repair mechanisms • BRCA1 • BRCA2 • cisplatin • drug resistance

Although ovarian carcinomas with mutated BRCA1 or BRCA2 are sensitive to platinum compounds, such carcinomas eventually develop platinum resistance. Previously, we showed that acquired resistance to cisplatin in BRCA2-mutated tumors can be mediated by secondary intragenic mutations in BRCA2 that restore the wild-type BRCA2 reading frame. Here, we show that secondary mutations of BRCA1 also occur in BRCA1-mutated ovarian cancer with platinum resistance. We evaluated nine recurrent BRCA1-mutated ovarian cancers previously treated with platinum compounds, including five with acquired platinum resistance, one with primary platinum resistance, and three with platinum sensitivity. Four of the six recurrent platinum-resistant tumors had developed secondary genetic changes in BRCA1 that restored the reading frame of the BRCA1 protein, whereas none of the three platinum-sensitive recurrent tumors developed BRCA1 sequence alterations. We immunohistochemically confirmed restored expression of BRCA1 protein in two cases with secondary mutations. Intriguingly, the case with primary platinum resistance showed back mutation of BRCA1 in the primary tumor and showed another secondary mutation in the recurrent tumor. Our results suggest that secondary mutations in BRCA1 can mediate resistance to platinum in BRCA1-mutated ovarian tumors. [Cancer Res 2008;68(8):2581–6]




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
J. M.-M. Kwok, B. Peck, L. J. Monteiro, H. D.C. Schwenen, J. Millour, R. C. Coombes, S. S. Myatt, and E. W.-F. Lam
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Mol. Cancer Res., January 1, 2010; 8(1): 24 - 34.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Sakai, E. M. Swisher, C. Jacquemont, K. V. Chandramohan, F. J. Couch, S. P. Langdon, K. Wurz, J. Higgins, E. Villegas, and T. Taniguchi
Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2-Mutated Ovarian Carcinoma
Cancer Res., August 15, 2009; 69(16): 6381 - 6386.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Kriege, C. Seynaeve, H. Meijers-Heijboer, J. M. Collee, M. B.E. Menke-Pluymers, C. C.M. Bartels, M. M.A. Tilanus-Linthorst, J. Blom, E. Huijskens, A. Jager, et al.
Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
J. Clin. Oncol., August 10, 2009; 27(23): 3764 - 3771.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. D. Iglehart and D. P. Silver
Synthetic Lethality -- A New Direction in Cancer-Drug Development
N. Engl. J. Med., July 9, 2009; 361(2): 189 - 191.
[Full Text] [PDF]


Home page
aacredbookHome page
V. L. Giranda and A. Shoemaker
From Concept to Clinical Trials: Evaluation of Poly (ADP-Ribose) Polymerase Inhibitor Preclinical Data and Its Use in the Design of Clinical Trials
Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 51 - 56.
[Full Text] [PDF]


Home page
Ann OncolHome page
J. Fasano and F. Muggia
Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development
Ann. Onc., April 1, 2009; 20(4): 609 - 614.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Saunus, J. D. French, S. L. Edwards, D. J. Beveridge, E. C. Hatchell, S. A. Wagner, S. R. Stein, A. Davidson, K. J. Simpson, G. D. Francis, et al.
Posttranscriptional Regulation of the Breast Cancer Susceptibility Gene BRCA1 by the RNA Binding Protein HuR
Cancer Res., November 15, 2008; 68(22): 9469 - 9478.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Rottenberg, J. E. Jaspers, A. Kersbergen, E. van der Burg, A. O. H. Nygren, S. A. L. Zander, P. W. B. Derksen, M. de Bruin, J. Zevenhoven, A. Lau, et al.
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
PNAS, November 4, 2008; 105(44): 17079 - 17084.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.